Peringatan Keamanan

Oral, mouse: LD50 = 440 mg/kg; Oral, rat: LD50 = 763 mg/kg; Symptoms of overdose include diarrhea, dizziness, drowsiness, headache, light-headedness, nausea, and vomiting.

Chlorzoxazone

DB00356

small molecule approved

Deskripsi

A centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. (From Martindale, The Extra Pharmacopoea, 30th ed, p1202)

Struktur Molekul 2D

Berat 169.565
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Chlorzoxazone is rapidly metabolized in the liver and is excreted in the urine, primarily in a conjugated form as the glucuronide.

Rute Eliminasi

Chlorzoxazone is rapidly metabolized and is excreted in the urine, primarily in a conjugated form as the glucuronide.

Interaksi Makanan

2 Data
  • 1. Avoid alcohol.
  • 2. Take with or without food. The absorption is unaffected by food.

Interaksi Obat

1668 Data
Deferasirox The serum concentration of Chlorzoxazone can be increased when it is combined with Deferasirox.
Peginterferon alfa-2b The serum concentration of Chlorzoxazone can be increased when it is combined with Peginterferon alfa-2b.
Leflunomide The serum concentration of Chlorzoxazone can be decreased when it is combined with Leflunomide.
Teriflunomide The serum concentration of Chlorzoxazone can be decreased when it is combined with Teriflunomide.
Buprenorphine Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Chlorzoxazone.
Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Chlorzoxazone.
Droperidol Droperidol may increase the central nervous system depressant (CNS depressant) activities of Chlorzoxazone.
Hydrocodone Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Chlorzoxazone.
Magnesium sulfate The therapeutic efficacy of Chlorzoxazone can be increased when used in combination with Magnesium sulfate.
Methotrimeprazine Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Metyrosine Chlorzoxazone may increase the sedative activities of Metyrosine.
Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Chlorzoxazone.
Mirtazapine Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Chlorzoxazone.
Orphenadrine Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Paraldehyde Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Chlorzoxazone.
Pramipexole Chlorzoxazone may increase the sedative activities of Pramipexole.
Ropinirole Chlorzoxazone may increase the sedative activities of Ropinirole.
Rotigotine Chlorzoxazone may increase the sedative activities of Rotigotine.
Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Chlorzoxazone.
Sodium oxybate Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
Suvorexant Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Chlorzoxazone.
Thalidomide Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Zolpidem Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Chlorzoxazone.
Mirabegron The serum concentration of Chlorzoxazone can be increased when it is combined with Mirabegron.
Abiraterone The serum concentration of Chlorzoxazone can be increased when it is combined with Abiraterone.
Cyproterone acetate The metabolism of Chlorzoxazone can be increased when combined with Cyproterone acetate.
Ethanol Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Azelastine Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Brimonidine Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Chlorzoxazone.
Citalopram The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Citalopram.
Trazodone The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Trazodone.
Sertraline The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Sertraline.
Sibutramine The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Sibutramine.
Zimelidine The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Zimelidine.
Dapoxetine The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Dapoxetine.
Milnacipran The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Milnacipran.
Desvenlafaxine The serum concentration of Chlorzoxazone can be increased when it is combined with Desvenlafaxine.
Seproxetine The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Seproxetine.
Levomilnacipran Chlorzoxazone may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.
Indalpine The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Indalpine.
Alaproclate The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Alaproclate.
Trospium The metabolism of Chlorzoxazone can be decreased when combined with Trospium.
Benzatropine Benzatropine may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.
Cyproheptadine The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Cyproheptadine.
Propiomazine The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Propiomazine.
Propantheline Chlorzoxazone may decrease the excretion rate of Propantheline which could result in a higher serum level.
Dicyclomine Chlorzoxazone may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Maprotiline The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Maprotiline.
Tolterodine Chlorzoxazone may decrease the excretion rate of Tolterodine which could result in a higher serum level.
Flavoxate Chlorzoxazone may decrease the excretion rate of Flavoxate which could result in a higher serum level.
Tiotropium Chlorzoxazone may decrease the excretion rate of Tiotropium which could result in a higher serum level.
Solifenacin The metabolism of Solifenacin can be decreased when combined with Chlorzoxazone.
Pizotifen The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Pizotifen.
Fesoterodine Chlorzoxazone may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
Aclidinium Chlorzoxazone may decrease the excretion rate of Aclidinium which could result in a higher serum level.
Umeclidinium The metabolism of Umeclidinium can be decreased when combined with Chlorzoxazone.
Trimebutine Chlorzoxazone may decrease the excretion rate of Trimebutine which could result in a higher serum level.
Imidafenacin Chlorzoxazone may decrease the excretion rate of Imidafenacin which could result in a higher serum level.
Revefenacin The metabolism of Revefenacin can be decreased when combined with Chlorzoxazone.
Propiverine Chlorzoxazone may decrease the excretion rate of Propiverine which could result in a higher serum level.
Quetiapine The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Quetiapine.
Doxepin The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Doxepin.
Zopiclone The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Zopiclone.
Albendazole The metabolism of Chlorzoxazone can be increased when combined with Albendazole.
Rifampin The metabolism of Chlorzoxazone can be increased when combined with Rifampicin.
Carbamazepine The metabolism of Chlorzoxazone can be increased when combined with Carbamazepine.
Primidone The metabolism of Chlorzoxazone can be increased when combined with Primidone.
Caffeine The metabolism of Chlorzoxazone can be decreased when combined with Caffeine.
Moxifloxacin The metabolism of Chlorzoxazone can be decreased when combined with Moxifloxacin.
Lidocaine The metabolism of Chlorzoxazone can be decreased when combined with Lidocaine.
Mexiletine The metabolism of Chlorzoxazone can be decreased when combined with Mexiletine.
Alosetron The metabolism of Chlorzoxazone can be decreased when combined with Alosetron.
Gatifloxacin The metabolism of Chlorzoxazone can be decreased when combined with Gatifloxacin.
Simeprevir The metabolism of Chlorzoxazone can be decreased when combined with Simeprevir.
Lobeglitazone The metabolism of Chlorzoxazone can be decreased when combined with Lobeglitazone.
Pazufloxacin The metabolism of Chlorzoxazone can be decreased when combined with Pazufloxacin.
Osilodrostat The metabolism of Chlorzoxazone can be decreased when combined with Osilodrostat.
Duloxetine The metabolism of Chlorzoxazone can be decreased when combined with Duloxetine.
Ritanserin The metabolism of Chlorzoxazone can be decreased when combined with Ritanserin.
Venlafaxine The risk or severity of CNS depression can be increased when Venlafaxine is combined with Chlorzoxazone.
Clobazam The serum concentration of Chlorzoxazone can be increased when it is combined with Clobazam.
Clozapine The serum concentration of Chlorzoxazone can be increased when it is combined with Clozapine.
Chlorpromazine The metabolism of Chlorzoxazone can be decreased when combined with Chlorpromazine.
Tranylcypromine The metabolism of Chlorzoxazone can be decreased when combined with Tranylcypromine.
Celecoxib The metabolism of Chlorzoxazone can be decreased when combined with Celecoxib.
Metoprolol The metabolism of Chlorzoxazone can be decreased when combined with Metoprolol.
Cimetidine The metabolism of Chlorzoxazone can be decreased when combined with Cimetidine.
Chloroquine The metabolism of Chlorzoxazone can be decreased when combined with Chloroquine.
Nicardipine The metabolism of Chlorzoxazone can be decreased when combined with Nicardipine.
Fusidic acid The metabolism of Chlorzoxazone can be decreased when combined with Fusidic acid.
Cholecalciferol The metabolism of Chlorzoxazone can be decreased when combined with Cholecalciferol.
Perhexiline The metabolism of Chlorzoxazone can be decreased when combined with Perhexiline.
Panobinostat The metabolism of Chlorzoxazone can be decreased when combined with Panobinostat.
Vilazodone The metabolism of Chlorzoxazone can be decreased when combined with Vilazodone.

Target Protein

Calcium-activated potassium channel subunit alpha-1 KCNMA1

Referensi & Sumber

Synthesis reference: Marsh, D.F.; US. Patent 2,895,877; July 21, 1959; assigned to McNeil Laboratories, Inc.
Artikel (PubMed)
  • PMID: 16859676
    Dong DL, Luan Y, Feng TM, Fan CL, Yue P, Sun ZJ, Gu RM, Yang BF: Chlorzoxazone inhibits contraction of rat thoracic aorta. Eur J Pharmacol. 2006 Sep 18;545(2-3):161-6. Epub 2006 Jun 29.
  • PMID: 16397290
    Park JY, Kim KA, Park PW, Ha JM: Effect of high-dose aspirin on CYP2E1 activity in healthy subjects measured using chlorzoxazone as a probe. J Clin Pharmacol. 2006 Jan;46(1):109-14.
  • PMID: 16393464
    Wan J, Ernstgard L, Song BJ, Shoaf SE: Chlorzoxazone metabolism is increased in fasted Sprague-Dawley rats. J Pharm Pharmacol. 2006 Jan;58(1):51-61.

Contoh Produk & Brand

Produk: 95 • International brands: 7
Produk
  • Acetazone Forte
    Tablet • - • Oral • Canada • OTC • Approved
  • Acetazone Forte C8
    Tablet • - • Oral • Canada • Approved
  • Back-aid Forte - Tab
    Tablet • - • Oral • Canada • OTC • Approved
  • Chlorzoxazone
    Tablet • 500 mg/1 • Oral • US • Generic • Approved
  • Chlorzoxazone
    Tablet • 250 mg/1 • Oral • US • Generic • Approved
  • Chlorzoxazone
    Tablet • 500 mg/1 • Oral • US • Generic • Approved
  • Chlorzoxazone
    Tablet • 500 mg/1 • Oral • US • Generic • Approved
  • Chlorzoxazone
    Tablet • 500 mg/1 • Oral • US • Generic • Approved
Menampilkan 8 dari 95 produk.
International Brands
  • Myoflexin — Zentiva
  • Paraflex — BioPhausia
  • Relaxazone
  • Remular
  • Remular-S
  • Solaxin — Eisai
  • Strifon Forte DSC

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul